Glenmark announces Q3 FY 2019 results
India, Feb. 15 -- Glenmark Pharma has announced its financial results for the third quarter ended December 31 of the financial year 2018-19.
In the third quarter ended December 31, 2018, Glenmark's consolidated revenue was at Rs. 25,550.45 Mn. (USD 355.87 Mn.) as against Rs. 22,036.62 Mn. (USD 340.69 Mn.) in the previous corresponding quarter, recording an increase of 15.95%. Consolidated Net Profit was at Rs. 1,163.41 Mn. for the quarter ended December 31, 2018 as compared to Rs. 1,047.43 Mn. in the previous corresponding quarter, registering an increase of 11.07%.
Consolidated EBITDA was at Rs. 4,346.80 Mn. in the quarter ended December 31, 2018 as against Rs. 3,226.93 Mn. in the previous corresponding quarter, an increase of 34.70%....
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.